Evaluation of Outcomes Using the Amo Advanced CustomVue Ilasik Procedure

NCT00765960 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-06-06

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure (WaveScan WaveFront® System, STAR S4 IR™ Excimer Laser System and IntraLase™ FS System).

Conditions

  • Myopia
  • Hyperopia

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Kerry D Solomon, MD · Professor of Ophthalmology

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2008-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00765960 on ClinicalTrials.gov